Do aromatase inhibitors have adverse effects on cognitive function?

Aromatase inhibitors are an important component of treatment for most postmenopausal women with hormone receptor-positive, early-stage breast cancer. Women taking aromatase inhibitors experience very low levels of circulating estrogen. This might be expected to result in cognitive dysfunction given...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Kelly Anne, Ribi, Karin, Fisher, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109568/
https://www.ncbi.nlm.nih.gov/pubmed/21392408
http://dx.doi.org/10.1186/bcr2806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109568/
https://www.ncbi.nlm.nih.gov/pubmed/21392408
http://dx.doi.org/10.1186/bcr2806

Ejemplares similares